Company Filing History:
Years Active: 2007-2009
Title: Janice E Rugaber: Innovator in Recombinant Polypeptide Technology
Introduction
Janice E Rugaber is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 2 patents to her name, her work has implications for various applications in medical and pharmaceutical research.
Latest Patents
Janice's latest patents focus on methods for producing recombinant histidine-tagged inosine monophosphate dehydrogenase (IMPDH) polypeptides. The first patent describes a modified IMPDH polypeptide that includes a histidine tag. This modification enhances the stability of the polypeptide compared to the wild-type version. The invention also encompasses methods, nucleic acid molecules, vectors, and host cells for producing these histidine-tagged polypeptides, along with kits that include the modified IMPDH polypeptide. The second patent mirrors the first, emphasizing the importance of the histidine tag in maintaining the stability of the modified IMPDH polypeptide.
Career Highlights
Janice E Rugaber is currently employed at Roche Diagnostics Operations, Inc., where she continues to advance her research in biotechnology. Her work has been instrumental in developing innovative solutions that enhance the production and stability of important polypeptides used in various applications.
Collaborations
Janice collaborates with her coworker, Allan R Dorn, to further her research initiatives. Their combined expertise contributes to the advancement of their projects and the overall goals of their organization.
Conclusion
Janice E Rugaber's contributions to the field of recombinant polypeptide technology highlight her innovative spirit and dedication to scientific advancement. Her patents reflect her commitment to improving biotechnological processes, making her a valuable asset in her field.